Cell Commun Signal. 2025 Feb 1;23(1):59.doi: 10.1186/s12964-025-02038-w. Dose-dependent role of AMH and AMHR2 signaling in male differentiation and regulation of sex determination in Spotted knifejaw (Oplegnathus punctatus) with X1X1X2X2/X1X2Y chromosome system
Adv Sci (Weinh). 2025 Jan 31:e2413333.doi: 10.1002/advs.202413333. LncRNA TUG1 Repressed Angiogenesis by Promoting the Ubiquitination of HuR and Inhibiting Its Nuclear Translocation in Cerebral Ischemic Reperfusion Injury LncRNA
Toxicol Res (Camb). 2025 Jan 26;14(1):tfaf009.doi: 10.1093/toxres/tfaf009. eCollection 2025 Feb. lncRNA PART1 improves sevoflurane-induced impairments in learning and cognitive function by regulating miR-16-5p expression and reducing neuroinflammation lncRNA
J Inflamm Res. 2025 Jan 25:18:1167-1189.doi: 10.2147/JIR.S494611. eCollection 2025. Interleukin-1 Receptor-Associated Kinase-3 Aggravates Neuroinflammatory Injury After Intracerebral Hemorrhage via Activation NF-κB/IL-17A Pathway in Mice
Int J Ophthalmol. 2025 Jan 18;18(1):39-50.doi: 10.18240/ijo.2025.01.05. eCollection 2025. HMGB2 knockdown ameliorates retinal ganglion cell injury by inhibiting NLRP3 inflammasome activation after retinal ischemia
Oncol Res. 2025 Jan 16;33(2):369-380.doi: 10.32604/or.2024.046774. eCollection 2025. Circ-PAN3 facilitates hepatocellular carcinoma growth via sponging miR-153 and upregulating cyclin D1
BMC Cancer. 2025 Jan 14;25(1):84.doi: 10.1186/s12885-025-13464-x. CircCCT2/miR-146a-5p/IRAK1 axis promotes the development of head and neck squamous cell carcinoma
Cancer Cell Int. 2025 Jan 13;25(1):10.doi: 10.1186/s12935-025-03638-9.Heterogeneous nuclear ribonucleoprotein C promotes non-small cell lung cancer progression by enhancing XB130 mRNA stability and translation
Biochim Biophys Acta Mol Basis Dis. 2025 Jan;1871(1):167498.doi: 10.1016/j.bbadis.2024.167498. Epub 2024 Sep 5. S100A4 mediates the accumulation and functions of myeloid-derived suppressor cells via GP130/JAK2/STAT3 signaling in acute myeloid leukemia
Mol Neurobiol. 2025 Nov 21;63(1):120.doi: 10.1007/s12035-025-05356-9. Fluvoxamine Attenuates Blood-Brain Barrier Disruption in Drug-Resistance Epilepsy and inhibits Ferroptosis via the Sigma-1 Receptor-TAMM41 signaling in bEnd.3 cells
